1. Home
  2. CVGI vs CRBU Comparison

CVGI vs CRBU Comparison

Compare CVGI & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commercial Vehicle Group Inc.

CVGI

Commercial Vehicle Group Inc.

HOLD

Current Price

$4.57

Market Cap

167.7M

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.60

Market Cap

166.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVGI
CRBU
Founded
2000
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
167.7M
166.6M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
CVGI
CRBU
Price
$4.57
$1.60
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$10.75
AVG Volume (30 Days)
359.4K
1.9M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
316.18
3.64
EPS
0.04
N/A
Revenue
$755,231,000.00
N/A
Revenue This Year
$4.84
$1.63
Revenue Next Year
$5.36
$10.93
P/E Ratio
$115.50
N/A
Revenue Growth
14.06
N/A
52 Week Low
$1.29
$1.38
52 Week High
$5.88
$3.53

Technical Indicators

Market Signals
Indicator
CVGI
CRBU
Relative Strength Index (RSI) 44.17 37.59
Support Level $4.32 $1.39
Resistance Level $5.77 $1.73
Average True Range (ATR) 0.29 0.11
MACD -0.01 -0.01
Stochastic Oscillator 16.67 5.56

Price Performance

Historical Comparison
CVGI
CRBU

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc and its subsidiaries are a globalised provider of systems, assemblies, and components to international commercial vehicle markets and electric vehicle markets. It delivers real solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities it serves. The company has its manufacturing operations in the United States, Mexico, China, the United Kingdom, the Czech Republic, Ukraine, Morocco, Thailand, India, and Australia. Organisations' products are mainly sold in North America, Europe, and the Asia-Pacific region. It has three segments: Global Seating Segment, Global Electrical systmem, and Trim Systems and Components Segment, with the majority of revenue from Global Seating Segment.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: